← Eichor
Study identifier: NCT07227376 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Data Collection Using Eko Digital Devices in a Clinical Setting

Condition: Lung Diseases  ·  Sponsor: Eko Devices, Inc.

PhaseN/A
Planned participants250
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The purpose of this research is to prospectively train and validate an artificial intelligence machine learning (ML) algorithm to detect the presence of adventitious lung sounds in adults. Clinicians will use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings to collect normal and abnormal lung sounds, as part of standard of care clinical practice, which will then be used to explore an ML algorithm for classifiers for wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough, as well as determine any correspondences between the type and/or location of adventitious lung sounds and the type of pulmonary conditions as reported by clinicians.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Research Associate  ·  8443563384  ·  jackrin.walsh@ekohealth.com

Always discuss trial participation with your own doctor first.

Locations (2)

Nemours Children's HealthJacksonville, Florida, United StatesRecruiting
Jefferson Einstein Philadelphia HospitalPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07227376